A major requirement both of national and international ethical codes for human experimentation, and of national legislation in many cases, is that new substances or devices should not be used for the fi rst time on human beings unless previous tests on animals have provided a reasonable presumption of their safety. Th at is so called: Good Clinical Praxis (GCP Animal experimentation is fundamental to the biomedical sciences, not only for the advancement of specifi c vital processes, but also for the improvement of methods of prevention, diagnosis, and treatment of disease both in man and in animals. Th e use of animals is also indispensable for testing the potency and safety of biological substances used in human and veterinary medicine, as well as for determining the toxicity of the rapidly growing number of molecules that never existed before in nature and which may represent a hazard to health. Th is extensive exploitation by man of animals implies philosophical and moral problems that are not peculiar to their use for scientifi c purposes, and there are no objective ethical criteria by which to judge claims and counterclaims in such matters [] . However, there is a consensus that "deliberate cruelty is repugnant". While many countries have general laws or regulations imposing penalties for ill-treatment of animals, relatively few make specifi c provision for their use for scientifi c purposes. Because of diff ering legal systems and cultural backgrounds there are varying approaches to the use of animals for research, testing, or training in diff erent countries. In the few that have done so, the measures adopted vary widely: on the one hand, legally enforceable detailed regulations with licensing of experimenters and their premises together with an offi cial inspectorate; on the other, entirely voluntary self-regulation by the biomedical community, with lay participation. Many variations are possible between these extremes, one intermediate situation being a legal requirement that experiments or other procedures involving the use of animals should be subject to the approval of ethical committees of specifi ed composition.
Th e International Guiding Principles are the product of the collaboration of a representative sample of the international biomedical community, including experts of the World Health Organization, and of consultations with responsible animal welfare groups. Th e International Guiding Principles have already gained a considerable measure of acceptance internationally. European Medical Research Councils (EMRC), an international association that includes all the West European medical research councils, fully endorsed the Guiding Principles in .
Here we bring the basic bioethical principles for using animals in biomedical research[]: . Methods such as mathematical models, computer simulation and in vitro biological systems should be used wherever appropriate, . Animal experiments should be undertaken only after due consideration of their relevance for human or animal health and the advancement of biological knowledge, . Th e animals selected for an experiment should be of an appropriate species and quality, and the minimum number required to obtain scientifi cally valid results, . Investigators and other personnel should never fail to treat animals as sentient, and should regard their proper care and use and the avoidance or minimization of discomfort, distress, or pain as ethical imperatives, . Procedures with animals that may cause more than momentary or minimal pain or distress should be performed with appropriate sedation, analgesia, or anesthesia in accordance with accepted veterinary practice. Surgical or other painful procedures should not be performed on unanesthetized animals paralyzed by chemical agents, . Where waivers are required in relation to the provisions of article V, the decisions should not rest solely with the investigators directly concerned but should be made, with due regard to the provisions of articles IV, and V, by a suitably constituted review body. Such waivers should not be made solely for the purposes of teaching or demonstration, . At the end of, or, when appropriate, during an experiment, animals that would otherwise suff er severe or chronic pain, distress, discomfort, or disablement that cannot be relieved should be painlessly killed, . Th e best possible living conditions should be maintained for animals kept for biomedical purposes. Normally the care of animals should be under the supervision of veterinarians having experience in laboratory animal science. In any case, veterinary care should be available as required, . It is the responsibility of the director of an institute or department using animals to ensure that investigators and personnel have appropriate qualifi cations or experience for conducting procedures on animals. Adequate opportunities shall be provided for in-service training, including the proper and humane concern for the animals under their care.
Also see Draft CIOMS Guiding Principles  to be used by the international scientifi c community to guide the responsible use of vertebrate animals in scientifi c and/or educational activities [] .
Th ere remain many areas in biomedical research which, at least for the foreseeable future, will require animal experimentation. An intact live animal is more than the sum of the responses of isolated cells, tissues or organs; there are complex interactions in the whole animal that cannot be reproduced by biological or non-biological "alternative" methods. Th e term "alternative" has come to be used by some to refer to a replacement of the use of living animals by other procedures, as well as methods which lead to a reduction in the numbers of animals required or to the refi nement of experimental procedures.
Th e experimental procedures that are considered to be "alternatives" include biological and non-biological methods. Th e biological methods include the use of micro-organisms, in vitro preparations (subcellular fractions, short-term cellular systems, whole organ perfusion, and cell and organ culture) and under some circumstances, invertebrates and vertebrate embryos. Th e non-biological methods include mathematical modeling of structure-activity relationships based on the physico-chemical properties of drugs and other chemicals, and computer modeling of other biological processes. In addition to experimental procedures, retrospective and prospective epidemiological investigations on human and animal populations represent other approaches of major importance.
Th ere no need specialy underline that the adoption of "alternative" approaches is viewed as being complementary to the use of intact animals and their development and use should be actively encouraged for both scientifi c and humane reasons.
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